Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

Effect of Daily Consumption of Peanuts on Immune Function and Cardiometabolic Markers and Risk Factors in Free-living Individuals: A Randomized Controlled Trial

The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.

The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors . To accomplish this objective, a human dietary intervention trial (RCT) with peanuts is proposed. The proposed study is a 12-week parallel-group, free-living, observer-blind, randomized controlled dietary intervention trial. This study will examine the effects of peanuts on markers of immune function, cardiometabolic markers and risk factors and upper respiratory tract infections, in 80 adult male and female volunteers.

Inclusion Criteria:

• adults between the ages of 18-70 years

Exclusion Criteria:

• known intolerance or allergy to peanuts
• bad dentures unable to chew peanuts
• regular intake of peanuts and/or other nuts (>3 ounces/week)
• use of immune-boosting supplements
• exposure to antibiotics and corticoids immediately prior to the study
• use of other medications or supplements that can interfere with the immune functions
• Individuals that received any vaccination (i.e flu or Covid 19) 6 months prior to the start of the study